Medical Developments International Limited (MDDVF) Research

Medical Developments International Limited is a global provider of essential medical solutions, engaged in both their manufacturing and distribution. The company's reach extends throughout Australia, Europe, the United States, and other international markets, with its operations divided into two primary segments: Pain Management and Respiratory. Within its respiratory division, it develops devices to assist individuals afflicted with conditions such as asthma and chronic obstructive pulmonary disease. For pain relief, a cornerstone product is Penthrox, utilized in trauma and emergency scenarios. Furthermore, Medical Developments International offers a diverse selection of medical instruments, including CPR equipment like face shield keyrings and masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, and various oxygen therapy and resuscitation kits and masks. Founded in 2003, the company's main office is located in Scoresby, Australia.

Market snapshot

Symbol
MDDVF
Price
$0.37
Day change
0.00%
Market cap
$46.8M
P/E ratio
-107.23x
52-week range
0.3038-0.5076
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 months

Peer companies

  • Atlas Energy Corp. (CANSF)
  • The Cannabist Company Holdings Inc. (CBSTF)
  • Drug Free Solution, Inc. (DSOL)
  • Ecofibre Limited (EOFBF)
  • Glass House Brands Inc. (GHBWF)
  • iAnthus Capital Holdings, Inc. (ITHUF)
  • Leef Brands Inc. (LEEEF)
  • Novacyt S.A. (NVYTF)

Open Medical Developments International Limited (MDDVF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.